Expansion opportunities Given SetPoint Medical’s recent partnerships with Lovell Government Services to expand access within federal healthcare systems, sales teams should target federal agencies, VA and DoD facilities, and bundled procurement programs to accelerate adoption of their neuroimmune therapy.

Commercial readiness With substantial private financing rounds totaling hundreds of millions and leadership hires focused on market access and reimbursement, position SetPoint for market entry by engaging payer analytics, health economics outcomes research (HEOR) teams, and hospital formulary committees to secure coverage and reimbursement.

Clinical validation Active participation in major conferences and upcoming clinical data presentations indicate a push to demonstrate efficacy in rheumatoid arthritis and related inflammatory indications; prioritize partnerships with academic centers, key opinion leaders, and rheumatology networks to accelerate evidence generation and adoption.

Neuroimmune edge SetPoint’s unique vagus nerve stimulation platform across neurological and inflammatory indications suggests cross-sell opportunities into neurology, pain management, and autoimmune clinics; align sales plays to spine, neuromodulation, and rheumatology practices seeking innovative anti-inflammatory therapies.

Technology & data The tech stack and integrated platform indicate reliance on enterprise systems and data-driven operations; offer integrative solutions with Epic and hospital IT ecosystems, plus post-market data capture via Wrike workflows and analytics to support service level commitments and outcomes tracking.